Search
Now showing items 21-26 of 26
A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management
(Elsevier, 2020-07)
Abstract
Introduction & objectives: Liver cirrhosis is a major cause of mortality worldwide. Adequate diagnosis and treatment of decompensating events requires of both medical skills and updated technical resources. The ...
Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases
(Elsevier, 2020-11)
Abstract
Introduction and objectives: After hepatitis A (HAV) mandatory immunization in 2005 in Argentina, the incidence of HAV declined drastically. However, several new autochthonous cases of HAV have been reported since ...
Developing multicenter consortia in liver disease in Latin America: Challenges and opportunities.
(Wiley, 2017-06-07)
The development of consortia has been useful for exploring challenging scenarios and uncharted territories in liver disease treatments. Several consortia already developed in the United States and Europe have become key ...
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
(Elsevier, 2021-11)
Abstract
Background & aims: Corticosteroids are the only effective therapy for severe alcohol-associated hepatitis (AH), defined by a model for end-stage liver disease (MELD) score >20. However, there are patients who may ...
Reply
(Elsevier, 2021-03)
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents.
(Elsevier, 2020-10)
Abstract
Background & aims: Little is known about how a sustained virologic response (SVR) to treatment of hepatitis C virus infection with direct-acting antivirals (DAAs) affects patient mortality and development of new ...